Aprea Therapeutics Inc Financial Flexibility Index
Aprea Therapeutics Inc financial flexibility index. Aprea Therapeutics Inc (APRE) has a Financial Flexibility Index of -0.85x as of June 2026. Free cash flow of $-3.26 Million (operating CF $-3.28 Million minus capex $15.40K) represents -1% of total liabilities ($3.82 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aprea Therapeutics Inc (2007–2025)
Financial flexibility index of Aprea Therapeutics Inc from 2007 to 2025. Historical Financial Flexibility Index trend for Aprea Therapeutics Inc across 10 annual periods. Explore APRE operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Aprea Therapeutics Inc Financial Flexibility Index by Year (2007–2025)
Aprea Therapeutics Inc financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Aprea Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Aprea Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.69x | $-12.89 Million | $-12.89 Million | $3.49 Million | ▼ -27.4% |
| 2024 | -2.90x | $-13.54 Million | $-13.56 Million | $4.67 Million | ▼ -5.2% |
| 2023 | -2.76x | $-12.08 Million | $-12.18 Million | $4.39 Million | ▲ +50.3% |
| 2022 | -5.54x | $-25.01 Million | $-25.01 Million | $4.51 Million | ▼ -7.6% |
| 2021 | -5.15x | $-37.69 Million | $-37.69 Million | $7.32 Million | ▼ -90.0% |
| 2020 | -2.71x | $-41.78 Million | $-41.80 Million | $15.41 Million | ▲ +4.8% |
| 2019 | -2.85x | $-26.68 Million | $-26.71 Million | $9.36 Million | ▼ -2094.8% |
| 2018 | -0.13x | $-15.25 Million | $-15.25 Million | $117.46 Million | ▲ +43.9% |
| 2017 | -0.23x | $-14.00 Million | $-14.00 Million | $60.53 Million | ▲ +70.4% |
| 2007 | -0.78x | $-1.90 Million | $-1.90 Million | $2.43 Million | — |